Your browser doesn't support javascript.
loading
Comparative analyses of nilotinib versus high-dose imatinib versus sustained standard-dose imatinib in patients with chronic phase chronic myeloid leukemia following suboptimal molecular response to first-line imatinib.
Lee, Sung-Eun; Choi, Soo-Young; Kim, Soo-Hyun; Jootar, Saengsuree; Kim, Hyeoung-Joon; Sohn, Sang-Kyun; Park, Joon Seong; Kim, Sung-Hyun; Zang, Dae-Young; Oh, Suk-Joong; Kim, Dong-Wook.
Afiliación
  • Lee SE; Leukemia Research Institute, The Catholic University of Korea, Seoul, Republic of Korea; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Choi SY; Leukemia Research Institute, The Catholic University of Korea, Seoul, Republic of Korea.
  • Kim SH; Leukemia Research Institute, The Catholic University of Korea, Seoul, Republic of Korea.
  • Jootar S; BMT Program, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Kim HJ; Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.
  • Sohn SK; Department of Oncology/Hematology, Kyungpook National University Hospital, Daegu, Republic of Korea.
  • Park JS; Department of Hematology/Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Kim SH; Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.
  • Zang DY; Department of Internal Medicine, Hallym University College of Medicine, Anyang, Republic of Korea.
  • Oh SJ; Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul, Republic of Korea.
  • Kim DW; Leukemia Research Institute, The Catholic University of Korea, Seoul, Republic of Korea; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Electronic address: dwkim@catholic.ac.kr.
Leuk Res ; 70: 100-105, 2018 07.
Article en En | MEDLINE | ID: mdl-29908417
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Inhibidores de Proteínas Quinasas / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Inhibidores de Proteínas Quinasas / Mesilato de Imatinib / Antineoplásicos Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido